表紙
市場調査レポート

体内神経刺激の世界市場 - 2019年までの予測:タイプ別 (脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、胃電気刺激)、用途別、地域別

Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application, by Geography - Analysis & Forecasts To 2019

発行 MicroMarketMonitor 商品コード 329349
出版日 ページ情報 英文 88 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
体内神経刺激の世界市場 - 2019年までの予測:タイプ別 (脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、胃電気刺激)、用途別、地域別 Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application, by Geography - Analysis & Forecasts To 2019
出版日: 2015年04月07日 ページ情報: 英文 88 Pages
概要

2014年の世界の体内神経刺激市場のうち、脊髄刺激分野は57.5%と最大のシェアを有しています。同市場は2014年の27億8,800万米ドルから2019年までに48億1,990万米ドルに達し、CAGR11.6%となるとみられています。これに次ぐのが脳深部刺激分野で、2014年の8億6,120万米ドルから2019年までCAGR12.9%で拡大し、15億8,140万米ドルになると予測されています。

当レポートでは、世界の体内神経刺激市場について詳細に分析し、タイプ別、用途別、地域別の動向、市場に参入する企業の詳細な競合動向とシェア、プロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 体内神経刺激市場
  • 市場促進因子と阻害因子

第5章 タイプ別

  • イントロダクション
  • 世界の脊髄刺激市場
  • 世界の脳深部刺激市場
  • 世界の迷走神経刺激市場
  • 世界の仙骨神経刺激市場
  • 世界の胃電気刺激市場

第6章 用途別

  • イントロダクション
  • パーキンソン病
  • 震え
  • 鬱病
  • その他

第7章 地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第8章 競合環境

  • 企業シェア分析
  • 製品別企業概要
  • 新製品上市
  • 法規制認可
  • 合併・買収
  • 協定

第9章 企業別市場

  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Depuy Synthes Companies
  • Enteromedics, Inc.
  • Medtronic, Plc.
  • St. Jude Medical
  • Synapse Biomedical, Inc.
  • Uroplasty, Inc.

第10章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HE 1046

Internal neurostimulation involves a surgical implantation of electrodes at specific areas, either in the dura mater or deep inside the brain. Medical practitioners measure the invasiveness of any surgical procedure or therapeutic device, based on incision size, collateral tissue damage, and recovery period. Thus, minimally invasive technologies are surgical techniques that reduce the physical impact of a medical procedure. The use of internal neurostimulation (minimally invasive) devices reduces the length of hospital stay, post-surgical complications, and improves the quality of life. The long-term cost savings associated with the use of minimally invasive neurostimulation devices has contributed to the significant growth of the internal neurostimulation market.

In addition to this, increasing neurostimulation research activities to treat diabetes, widespread awareness associated with the benefits of neurostimulation methods, and growing prevalence of neurological disorders have equally contributed to the overall growth of the global internal neurostimulation market.

The global internal neurostimulation market was valued at $4,850.1 million in 2014, and is expected to reach $8,585.1 million by 2019, at a CAGR of 12.1% from 2014 to 2019. The North American internal neurostimulation market was valued at $2,513.0 million in 2014, and is expected to reach $4,186.1 million by 2019, at a CAGR of 10.7% during the forecast period.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the internal neurostimulation market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Product Analysis and development:Detailed insights on upcoming technologies, research and development activities, and new product launches in the global internal neurostimulation market. Usage pattern/ penetration rate (in-depth trend analysis) of products (Segment wise), and purchasing data. Comprehensive coverage of product approvals and product recalls.
  • Market Development:Comprehensive information about emerging markets
  • Market Diversification:Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the global internal neurostimulation market. Detailed description regarding the related and unrelated diversification pertaining to this market.
  • Competitive Assessment:In-depth assessment of market shares and company share analysis of key players. Develop business strategies and manufacturing capabilities of leading players that enhance the bottom line of companies in the global internal neurostimulation market.
  • Product/ Brand Perception Analysis:Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language), by checking the virality and tonality of blogs.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF THE INTERNAL NEUROSTIMULATION MARKET
  • 2.2. ARRIVING AT THE INTERNAL NEUROSTIMULATION MARKET SIZE
    • 2.2.1. TOP-DOWN APPROACH
    • 2.2.2. BOTTOM-UP APPROACH
    • 2.2.3. MACROINDICATOR-BASED APPROACH
  • 2.3. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET
  • 4.3. MARKET DRIVERS AND INHIBITORS

5. INTERNAL NEUROSTIMULATION MARKET, BY TYPE

  • 5.1. INTRODUCTION
  • 5.2. GLOBAL: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY
  • 5.3. GLOBAL DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY
  • 5.4. GLOBAL SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY
  • 5.5. SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019(USD MN)
  • 5.6. GLOBAL VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY
  • 5.7. GLOBAL GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY

6. INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE , BY GEOGRAPHY
  • 6.3. GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY
  • 6.4. GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY
  • 6.5. GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS , BY GEOGRAPHY

7. INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET
    • 7.2.1. NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.2.2. NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 7.3. EUROPE INTERNAL NEUROSTIMULATION MARKET
    • 7.3.1. EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.3.2. EUROPE INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 7.4. ASIA: INTERNAL NEUROSTIMULATION MARKET
    • 7.4.1. ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.4.2. ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 7.5. ROW INTERNAL NEUROSTIMULATION MARKET
    • 7.5.1. ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION
    • 7.5.2. ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE

8. INTERNAL NEUROSTIMULATION MARKET: COMPETITIVE LANDSCAPE

  • 8.1. INTERNAL NEUROSTIMULATION MARKET: BY COMPANY
  • 8.2. COMPANY PRESENCE IN INTERNAL NEUROSTIMULATION MARKET, BY TYPE
  • 8.3. NEW PRODUCT LAUNCH
  • 8.4. REGULATORY APPROVALS
  • 8.5. AGREEMENTS

9. INTERNAL NEUROSTIMULATION MARKET, BY COMPANY (Overview, Financials, Products & Services, Strategy, and Developments)*

  • 9.1. BOSTON SCIENTIFIC CORPORATION (U.S.)
  • 9.2. CYBERONICS, INC. (U.S.)
  • 9.3. DEPUY SYNTHES COMPANIES (U.S.)
  • 9.4. ENTEROMEDICS, INC. (U.S.)
  • 9.5. MEDTRONIC, PLC. (U.S.)
  • 9.6. ST. JUDE MEDICAL (U.S.)
  • 9.7. SYNAPSE BIOMEDICAL, INC. (U.S.)
  • 9.8. UROPLASTY, INC. (U.S.)

*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company

10. APPENDIX

  • 10.1. CUSTOMIZATION OPTIONS
    • 10.1.1. PRODUCT ANALYSIS
    • 10.1.2. EPIDEMIOLOGY DATA
    • 10.1.3. SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
    • 10.1.4. REGULATORY FRAMEWORK
  • 10.2. RELATED REPORTS
  • 10.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • 10.3.1. SNAPSHOTS

LIST OF TABLES

  • TABLE 1: GLOBAL INTERNAL NEUROSTIMULATION PEER MARKET SIZE, 2014 (USD MN)
  • TABLE 2: GLOBAL INTERNAL NEUROSTIMULATION MARKET: MACROINDICATORS, BY GEOGRAPHY, 2014 (USD MN)
  • TABLE 3: GLOBAL: INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET, 2013-2019 (USD MN)
  • TABLE 4: INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2014 (USD MN)
  • TABLE 5: GLOBAL: INTERNAL NEUROSTIMULATION MARKET: DRIVERS AND INHIBITORS
  • TABLE 6: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 7: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 8: DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 9: VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 10: GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 11: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 12: GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 13: GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 14: GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY, 2013-2019(USD MN)
  • TABLE 15: GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS, BY GEOGRAPHY, 2013-2019(USD MN)
  • TABLE 16: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • TABLE 17: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 18: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 19: EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 20: EUROPE: INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 21: ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 22: ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019(USD MN)
  • TABLE 23: ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • TABLE 24: ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • TABLE 25: INTERNAL NEUROSTIMULATION MARKET, BY COMPANY
  • TABLE 26: INTERNAL NEUROSTIMULATION MARKET: COMPANY SHARE ANALYSIS, 2013(%)
  • TABLE 27: GLOBAL INTERNAL NEUROSTIMULATION MARKET: NEW PRODUCT LAUNCH
  • TABLE 28: GLOBAL INTERNAL NEUROSTIMULATION MARKET: REGULATORY APPROVALS
  • TABLE 29: GLOBAL INTERNAL NEUROSTIMULATION MARKET: AGREEMENTS
  • TABLE 30: BOSTON SCIENTIFIC CORPORATION: REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 31: BOSTON SCIENTIFIC: REVENUE, BY GEOGRAPHICAL SEGMENTS, 2009 - 2012 (USD MN)
  • TABLE 32: CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN)
  • TABLE 33: JOHNSON & JOHNSON, INC. : REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 34: JOHNSON & JOHNSON, INC.: REVENUE, 2009 - 2013 (USD MN)
  • TABLE 35: MEDTRONIC, INC. : REVENUE, BY BUSINESS SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 36: MEDTRONIC, INC. : REVENUE, BY GEOGRAPHICAL SEGMENT, 2009 - 2013 (USD MN)
  • TABLE 37: ST. JUDE MEDICAL: REVENUE, BY BUSINESS SEGMENT, 2011 - 2013 (USD MN)
  • TABLE 38: ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHICAL SEGMENT, 2008 - 2013 (USD MN)
  • TABLE 39: UROPLASTY, INC. : REVENUE, BY GEOGRAPHICAL SEGMENT, 2011 - 2013 (USD MN)

LIST OF FIGURES

  • FIGURE 1: GLOBAL NEUROSTIMULATION MARKET: SEGMENTATION & COVERAGE
  • FIGURE 2: INTERNAL NEUROSTIMULATION MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: RESEARCH METHODOLOGY
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: MACROINDICATOR BASED APPROACH
  • FIGURE 7: GLOBAL INTERNAL NEUROSTIMULATION MARKET SNAPSHOT
  • FIGURE 8: INTERNAL NEUROSTIMULATION MARKET: COMPARISON WITH PARENT MARKET
  • FIGURE 9: GLOBAL : INTERNAL NEUROSTIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 10: GLOBAL: INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 11: GLOBAL: SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 12: GLOBAL: DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 13: GLOBAL: SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 14: GLOBAL: VAGUS NERVE STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 15: GLOBAL: GASTRIC ELECTRICAL STIMULATION MARKET, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 16: GLOBAL INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 17: GLOBAL INTERNAL NEUROSTIMULATION IN PARKINSON'S DISEASE, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 18: GLOBAL INTERNAL NEUROSTIMULATION IN TREMOR, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 19: GLOBAL INTERNAL NEUROSTIMULATION IN DEPRESSION, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 20: GLOBAL INTERNAL NEUROSTIMULATION IN OTHER APPLICATIONS, BY GEOGRAPHY, 2013-2019 (USD MN)
  • FIGURE 21: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 22: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 23: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 24: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 25: NORTH AMERICA INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 26: EUROPE INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 27: EUROPE INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 28: EUROPE INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 29: EUROPE INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 30: EUROPE: INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 31: ASIA INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 32: ASIA INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 33: ASIA INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 34: ASIA INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019 (USD MN)
  • FIGURE 35: ASIA INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 36: ROW INTERNAL NEUROSTIMULATION MARKET OVERVIEW, 2014 & 2019 (%)
  • FIGURE 37: ROW INTERNAL NEUROSTIMULATION MARKET, BY APPLICATION, 2013-2019 (USD MN)
  • FIGURE 38: ROW INTERNAL NEUROSTIMULATION MARKET: APPLICATION SNAPSHOT
  • FIGURE 39: ROW INTERNAL NEUROSTIMULATION MARKET, BY TYPE, 2013-2019(USD MN)
  • FIGURE 40: ROW: INTERNAL NEUROSTIMULATION MARKET SHARE, BY TYPE, 2013-2019 (%)
  • FIGURE 41: INTERNAL NEUROSTIMULATION: COMPANY PRODUCT COVERAGE, BY TYPE, 2013
  • FIGURE 42: BOSTON SCIENTIFIC CORPORATION REVENUE MIX, 2013
  • FIGURE 43: JOHNSON & JOHNSON, INC. REVENUE MIX, 2013
  • FIGURE 44: MEDTRONIC, PLC. REVENUE MIX, 2013
  • FIGURE 45: ST. JUDE MEDICAL. REVENUE MIX, 2013
Back to Top